XML 40 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

WARRANTS | 12 Months Ended
--- | ---
Dec. 31, 2022
Warrants |
WARRANTS | 20. WARRANTS A summary of warrant activity for the years ended December 31, 2022 and 2021 is presented below.
Schedule of warrants |  |  |  |  |  |  |  |  |  |  |  |
|  | Warrants |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Life (Years) |
Outstanding at January 1, 2021 |  |  | 3,315,560 |  |  | $ | 6.19 |  |  |  | 4.3 |
Granted |  |  | 18,665,252 |  |  |  | 2.47 |  |  |  |  |
Forfeited |  |  | (397 | ) |  |  | 8.00 |  |  |  |  |
Exercised |  |  | (1,965,628 | ) |  |  | 2.42 |  |  |  |  |
Outstanding at December 31, 2021 |  |  | 20,014,787 |  |  |  | 3.09 |  |  |  | 4.7 |
Granted |  |  | 9,066,666 |  |  |  | 0.60 |  |  |  |  |
Forfeited |  |  | (3,998 | ) |  |  | 607.30 |  |  |  |  |
Exercised |  |  | (13,548,421 | ) |  |  | 2.22 |  |  |  |  |
Outstanding at December 31, 2022 |  |  | 15,529,034 |  |  | $ | 2.24 |  |  |  | 3.9 |
The following table summarizes information about common stock warrants outstanding at December 31, 2022:
Schedule of common stock warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding |  |  | Exercisable |
|  |  |  |  |  | Weighted |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Average |  |  | Weighted |  |  |  |  |  | Weighted |
|  |  |  |  |  | Remaining |  |  | Average |  |  |  |  |  | Average |
Exercise |  |  | Number |  |  | Contractual |  |  | Exercise |  |  | Number |  |  | Exercise |
Price |  |  | Outstanding |  |  | Life (Years) |  |  | Price |  |  | Exercisable |  |  | Price |
$0.00 |  |  |  | 6,500 |  |  | 1.25 |  |  | $ | 0.00 |  |  |  | 6,500 |  |  | $ | 0.00 |
$0.45 - $2.50 |  |  |  | 15,454,885 |  |  | 3.91 |  |  | $ | 1.38 |  |  |  | 15,454,885 |  |  | $ | 1.38 |
$8.80 - $19.80 |  |  |  | 53,055 |  |  | 1.39 |  |  | $ | 12.78 |  |  |  | 53,055 |  |  | $ | 12.78 |
$480 - $920 |  |  |  | 12,227 |  |  | 0.34 |  |  | $ | 774.63 |  |  |  | 12,227 |  |  | $ | 774.63 |
$1,040 - $2,000 |  |  |  | 2,367 |  |  | 0.18 |  |  | $ | 1,404.85 |  |  |  | 2,367 |  |  | $ | 1,404.85 |
$0.00 - $2,000.00 |  |  |  | 15,529,034 |  |  | 3.89 |  |  | $ | 2.24 |  |  |  | 15,529,034 |  |  | $ | 2.24 |
Warrant Issuances During 2021 On December 30, 2021, the Company issued warrants to purchase an aggregate of 16,037,858 shares of common stock at an exercise price equal to $2.50 per share in connection with the issuance of promissory notes in the aggregate principal face amount of $66 million (see Note 24). If the trading price of the common stock is less than $2.50 per share 90 days after December 30, 2021, the exercise price will be reduced to 110% of the closing price of the common stock on that date, subject to a floor price of $1.00 per share. The Company has valued the 14,095,350 Series A warrants issued in connection with the issuance of promissory notes in the aggregate principal face amount of $66 million (see Note 24) at their date of grant utilizing a Monte Carlo simulation valuation model. The Company has valued the other warrants issued at their date of grant utilizing the Black-Scholes option pricing model. This model is dependent upon several variables such as the warrants’ remaining contractual term, exercise price, current stock price, risk-free interest rate and estimated volatility of the Company’s stock over the contractual term of the warrants. The risk-free interest rate used in the calculations is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the contractual life of the warrants. Warrant Issuances During 2022 On November 7, 2022, the Company issued warrants to purchase 4,533,334 shares of common stock at exercise price equal to $0.45 per share and warrants to purchase 4,533,334 shares of common stock at exercise price equal to $0.75 per share, subject to adjustment in connection with the issuance of secured promissory notes in the aggregate principal face amount of $18.9 million (see Note 24). The Company has valued the warrants issued at their date of grant utilizing the Black-Scholes option pricing model. This model is dependent upon several variables such as the warrants’ remaining contractual term, exercise price, current stock price, risk-free interest rate and estimated volatility of the Company’s stock over the contractual term of the warrants. The risk-free interest rate used in the calculations is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the contractual life of the warrants. The Company utilized a variety of pricing models and the weighted average assumptions used during the years ended December 31, 2022 and 2021 were as follows:
Schedule of weighted average assumptions |  |  |  |  |  |  |  |
|  | December 31, 2022 |  |  | December 31, 2021 |
Exercise price |  | $ | 0.60 |  |  | $ | 2.29 |
Contractual term in years |  |  | 4.0 |  |  |  | 4.7 |
Volatility |  |  | 176 | % |  |  | 150 | %
Dividend yield |  |  | 0 | % |  |  | 0 | %
Risk-free interest rate |  |  | 4.5 | % |  |  | 1.0 | %

X
- References No definition available. + Details
Name: | ault_DisclosureWarrantsAbstract
Namespace Prefix: | ault_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ault_WarrantsTextBlock
Namespace Prefix: | ault_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration